Riccioni Graziano, Speziale Giuseppe, Scotti Luca, Bucciarelli Valentina, Cappetti Silvia, Nasso Giuseppe, Gallina Sabina, Bucciarelli Tonino
Intensive Cardiology Care Unit, San Camillo De Lellis Hospital, Manfredonia, Foggia, Italy
Cardiac Surgery, Anthea Hospital, GVM Care and Research, Bari, Italy.
Int J Immunopathol Pharmacol. 2016 Mar;29(1):137-9. doi: 10.1177/0394632015599701. Epub 2015 Dec 17.
We describe a case of a 35-year-old man presented at the emergency room of our institution with acute onset of dyspnea and dizziness. He was a body builder and had been using Xenadrine EFX for weight loss reduction. The laboratory analyses were normal. A chest radiograph showed an enlarged cardiac silhouette with clear lung fields. Transtoracic two-dimensional color Doppler echocardiography revealed a diffuse hypokinesia with a marked decreased in systolic function and a high teledyastolic diameter. This case document the possible relation to use of Xenadrine EFX for weight loss and the recurrence of dilated cardiomyopathy.
我们描述了一例35岁男性患者,他因急性呼吸困难和头晕到我院急诊室就诊。他是一名健美运动员,一直在使用Xenadrine EFX进行减肥。实验室分析结果正常。胸部X光片显示心脏轮廓增大,肺野清晰。经胸二维彩色多普勒超声心动图显示弥漫性运动减弱,收缩功能明显降低,舒张末期直径增大。该病例记录了使用Xenadrine EFX减肥与扩张型心肌病复发之间可能存在的关联。